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ABSTRACT: Whole mitochondrial (mt) genome analysis
enables a considerable increase in analysis throughput,
and improves the discriminatory power to the maximum
possible phylogenetic resolution. Most established proto-
cols on the different massively parallel sequencing (MPS)
platforms, however, invariably involve the PCR amplifi-
cation of large fragments, typically several kilobases in
size, which may fail due to mtDNA fragmentation in the
available degraded materials. We introduce a MPS tiling
approach for simultaneous whole human mt genome se-
quencing using 161 short overlapping amplicons (average
200 bp) with the Ion Torrent Personal Genome Machine.
We illustrate the performance of this new method by se-
quencing 20 DNA samples belonging to different world-
wide mtDNA haplogroups. Additional quality control,
particularly regarding the potential detection of nuclear in-
sertions of mtDNA (NUMTs), was performed by compar-
ative MPS analysis using the conventional long-range am-
plification method. Preliminary sensitivity testing revealed
that detailed haplogroup inference was feasible with 100
pg genomic input DNA. Complete mt genome coverage
was achieved from DNA samples experimentally degraded
down to genomic fragment sizes of about 220 bp, and up to
90% coverage from naturally degraded samples. Overall,
we introduce a new approach for whole mt genome MPS
analysis from degraded and nondegradedmaterials relevant
to resolve and infer maternal genetic ancestry at complete
resolution in anthropological, evolutionary, medical, and
forensic applications.
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Introduction
Previous years have witnessed conspicuous progress in the es-
tablishment of the high-copy-number human mitochondrial DNA
(mtDNA) as an imperative tool in forensic, anthropological, and
medical genetics. This small, circular, double-stranded genome has
enthralled fundamental and applied geneticists with its unique fea-
tures, bolstering its recognized value as a useful molecular marker
when analyzing degraded or low-copy-number DNA samples, as
often confronted at crime scenes, from old and ancient human
remains, and from limited samples available in medical and an-
thropological applications. The higher mutation rate of mtDNA
as compared with nuclear DNA, and the resulting significant se-
quence variability between maternally unrelated individuals, has
made mtDNA an indispensable tool in various applications par-
ticularly forensics and anthropology [Wilson et al., 1995a, 1995b;
Holland and Parsons, 1999; Kivisild, 2015]. Most applications em-
ploy traditional Sanger sequencing of (the hypervariable portions
of) the noncoding control region of themt genome to delineate hap-
lotypes that enable maternal lineage identification [e.g., Gill et al.,
1994; Wilson et al., 1995a; Holland and Parsons, 1999; Brandsta¨tter
et al., 2007; Palo et al., 2007]. In addition to being labor-intensive
and expensive, the control-region Sanger sequencing approach does
not always allow reliable inference of maternal haplogroups, due to
the high level of homoplasy in the control region that can obscure
phylogenetic signatures [Schlebusch et al., 2009; King et al., 2014]
as well as the fact that many haplogroup-defining variants are lo-
cated outside the control region. Since not all the major mtDNA
haplogroups can be distinguished through control-region sequenc-
ing only, several studies [Schlebusch et al., 2009; van Oven et al.,
2011; Ballantyne et al., 2012] have resorted to the use of multiplex
single-base primer extension assays for simultaneous genotyping of
a limited number of mtDNA coding-region SNPs to improve ma-
ternal haplogroup definition. However, such assays are hampered
by technical limitations in terms of multiplexing capacity allowing
not more than 20–40 SNPs in a single multiplex assay.
Whole mtDNA genome sequencing would augment the haplo-
type andhaplogroup resolution to themaximumpossible resolution
level, thereby greatly enhancing the discriminatory power, and al-
lowing inference of matrilineal biogeographic ancestry at a greater
resolution; however, whole mtDNA genome analysis via Sanger se-
quencing is highly labor-intensive given the >16 kb involved [Fendt
et al., 2009; Ramos et al., 2009].Massively parallel sequencing (MPS)
or next-generation sequencing (NGS) technology in principle pro-
vides a solution to simultaneous whole mtDNA genome analysis
allowing high-throughput analysis at reduced per-sample costs. It
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hadbeenpioneered in thefieldof ancientDNAanalysiswheredegra-
dationproblems aremost severe. The shotgun-sequencing approach
usingMPS technology has facilitated the complete mtDNA genome
analysis of extinct nonhuman species such as mammoths [Gilbert
et al., 2007, 2008], cave bears, and others [Miller et al., 2009; Stiller
et al., 2009;Willerslev et al., 2009;Lindqvist et al., 2010;Ho&Gilbert,
2010] as well as extinct human species such as Neanderthals [Green
et al., 2008]. Recently, Davis et al. (2015) used the MPS approach
to analyze the hypervariable segments (HVS)-I and II of human
mtDNA using short amplicons in tissue and bone samples keeping
with the previously discussed limitations of partial mtDNA analysis.
However, themost established currently availableMPS protocols for
whole mtDNA genome sequencing are based on PCR amplification
of large mtDNA fragments, typically several kilobases in size [Sosa
et al., 2012; Parson et al., 2013], which fail when applied to degraded
DNA as encountered in many mtDNA applications. A very recent
publication [Parson et al., 2015] described a midi-sized amplicon
approach for whole mtDNA MPS analysis using 62 PCR ampli-
cons of 300–500 bp (average about 380 bp) in two multiplex assays,
which proved useful for human hair analysis. However, many DNA
samples encountered in mtDNA testing, especially for forensic and
anthropological purposes are more severely degraded resulting in
smaller-sized fragments.
Recently, we introduced a MPS tool based on short amplicons
(203 bp on average) using the Ion Torrent Personal Genome Ma-
chine (PGMTM) for simultaneous analysis of >530 Y-chromosome
SNPs covering the entire phylogenetic Y-chromosome tree that al-
lows classification of Y chromosomes into >430 worldwide Y hap-
logroups for ultra-high-resolution paternal lineage and paternal
ancestry inference [Ralf et al., 2015]. As a maternal counterpart,
with this study we introduce a short amplicon-based MPS tiling
approach for simultaneous whole mtDNA genome analysis using
the Ion Torrent PGMTM allowing to obtain maximum-resolution
maternal lineage and maternal ancestry inference from degraded
and nondegraded DNA. We tested the performance of the newly
developed method using geographically diverse DNA samples with
available whole mtDNA genome data based on Sanger sequencing,
and using samples for which we generated whole mtDNA genome
data based on an alternative MPS protocol. Additionally, we as-
sessed the efficacy of sample pooling, the sensitivity, and the robust-
ness of our new approach regarding experimental and natural DNA
degradation.
Materials and Methods
Primer Design
Primer pairs were designed for a total of 161 partially overlapping
amplicons in two separate primer pools (pool 1 with 80 pairs and
pool 2 with 81 pairs). Each individual primer pool produces a bat-
tery of amplicons separated by gaps across the entire mt genome.
By combining the PCR amplicons resulting from each primer pool,
the gaps were complemented by amplicons from the other primer
pool and the entire 16.5-kb mt genome could be covered. Ampli-
cons of comparable sizes were preferred (200 bp); however, some
regions proved to be difficult to amplify because of, for example,
high GC content or repetitive sequences. Also, highly polymorphic
positions need to be avoided to overlap with primer annealing sites
as much as possible; to overcome these issues, primer positions
had to be shifted leading to more variation in amplicon size. Sev-
eral rounds of test sequencing and primer redesigning were needed
to get to the final protocol. All primers were synthesized by Life
Technologies, a part of Thermo Fisher Scientific Inc., using their
proprietary AmpliSeqTM modification, which allows multiplexing
hundreds or even thousands of targets in one reaction. The primers
were all received at a concentration of 614 μM. For each pool, 1
μl of each primer is combined and each pool is then brought to a
volume of 3,070 μl. Each primer is now at a concentration of 200
nM. For the 20-μl PCR, 10 μl of primer pool is used, so the final
concentration in the PCR is 100 nM for each primer. Supp. Table S1
outlines the primer sequences used in this study without the propri-
etary modification. In the final version, and with the primer pools 1
and 2 together, the entire humanmtDNA genome is covered via 161
overlapping amplicons with fragment size of 144–230 bp (average
across amplicons: 200 bp).
DNA Samples
With the aim to cover the global variation of the mtDNA phy-
logeny [van Oven and Kayser 2009], 20 DNA samples known to
belong to widely divergent haplogroups were selected from four
different sources: the Centre d’Etude du Polymorphisme Humain
(CEPH, Paris, France) Human Genome Diversity Project (HGDP)
panel (http://www.ceph.fr/HGDP-CEPH-Panel), individuals from
across The Netherlands [Lao et al., 2013], the commercially avail-
able Ethnic Diversity DNA panel (EDP-1) manufactured by the
European Collection of Cell Cultures (ECACC) (http://www.phe-
culturecollections.org.uk/products/dna/ethnicdna.jsp), and dis-
tributed by Sigma, and volunteers recruited at the Erasmus MC
with informed consent.
Library Construction
DNA libraries were constructed with 10 ng of input DNA us-
ing the Ion AmpliseqTM Library Kit 2.0 (Life Technologies, a part
of Thermo Fisher Scientific Inc., Foster City, CA) and 18 cycles
with two separate primer pools, amplifying the 161 amplicons si-
multaneously, following themanufacturer’s recommendations. The
quantity of DNA was determined using the Qubit R© dsDNA BR
Quantification Kit and a Qubit R© 2.0 Fluorometer (Invitrogen, Life
Technologies, a part of Thermo Fisher Scientific Inc., Grand Island,
NY). In order to test the feasibility of sequencing multiple samples
simultaneously, Ion XpressTM Barcode Adapters (Life Technologies,
a part of Thermo Fisher Scientific Inc.) were used.
To evaluate the sensitivity of the tiling approach, variable amounts
of DNA input ranging from 10 ng to 100 pg were run and their se-
quences were evaluated. Three of the 20 DNA samples, hailing from
different populations—Italy (haplogroup, T2b), The Netherlands
(haplogroup, V3c), and South Africa (haplogroup, L3d3a1a), were
sequenced at 10 and 1 ng, 500, 250, and 100 pg of genomic DNA
input. All the DNA dilutions were quantified and confirmed in
duplicates with the Quantifiler R© Human DNA Quantification kit
(Applied Biosystems, Foster City, CA) following the manufacturer’s
guidelines.
The robustness of the assay to successfully type degraded mate-
rials was tested by subjecting an additional DNA sample (in this
case from an Indian individual belonging to mtDNA haplogroup
M35a) to DNase I treatment at different time intervals: 5, 10, 15,
20, 30, and 45 min. Three microliter of each of these DNase-treated
samples was used for the MPS. Furthermore, sample 15 (from Italy
with haplogroup T2b) was subjected to two different degradation
methods—exposure to ultraviolet (UV) light for 30 min using a
Bio-Link (Vilber Lourmat) at a strength of 50 J/cm2 and enzymatic
shearing using the Ion ShearTM Plus Reagents Kit (Life Technologies,
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a part of Thermo Fisher Scientific Inc.). Three microliter of each of
the degraded samples was used for the NGS.
In addition, we applied our whole mt genome MPS method to
DNA extracted from six different bones and teeth samples fromnat-
urally degraded human remains found in Poland. Samples 1, 2, 4,
5, and 6 were extracted from teeth, whereas sample 3 was extracted
from a femoral bone. Samples 1, 3, 4, and 5 gave a full profile with
the AmpFSTR R© NGMTM (Applied Biosystems), whereas samples
2 and 6 gave partial profiles with only 4 and 6 loci, respectively, out
of the 16 loci (15 STRs plus amelogenin) of a full NGM profile.
For samples 4, 5, and 6, the control region was analyzed via the
Sanger sequencing (unpublished study). The remains that gave rise
to sample 2 are believed to be from an archaeological stand from the
XV–XVI century. Sample 5 likely comes from a recently deceased
individual as decomposed soft tissue was found together with the
hard tissues. The remains that gave rise to sample 1 were found
in soil and the time since death was reported to be approximately
7–8 months, whereas those of sample 3 were found in a river. The
samples 1–6 were PCR-quantified using the Quantifiler R© Human
DNAQuantification Kit (Applied Biosystems) and their concentra-
tions were 0.05, 0.1, 0.045, 5.4, 1.82, and 0.4 ng/μl, respectively. For
MPS, we used 4 μl of each of the samples.
Furthermore, as a comparison to currently available NGS assays,
five out of the 20 DNA samples were also sequenced using a dif-
ferent library preparation method. The entire mtDNA genome was
amplifiedwith twooverlapping >8 kb fragments using the amplifica-
tion primers from Fendt et al. (2009). The SequalPrepTM Long PCR
Kit with dNTPs (Invitrogen) was used for the long-range amplifica-
tion following themanufacturer’s guidelines. The amplified samples
were quantifiedusing theQubit R© dsDNABRQuantificationKit and
a Qubit R© 2.0 Fluorometer (Invitrogen) and the amplified samples
were normalized to 100ng of inputDNA. Librarieswere constructed
using the Ion ShearTM Plus Reagents Kit (Life Technologies, a part
of Thermo Fisher Scientific Inc.) for enzymatic fragmentation of
DNA, followed by barcoded adapter ligation using the Ion XpressTM
Barcode Adapters (Life Technologies, a part of Thermo Fisher Sci-
entific Inc.) and Ion Plus Fragment Library Kit (Life Technologies, a
part of Thermo Fisher Scientific Inc.) as per themanufacturer’s pro-
tocol. The libraries were size selected using the E-Gel R© SizeSelectTM
2% Agarose Gel (Invitrogen, Carlsbad, CA).
Template Preparation
Using emulsion PCR, the generated libraries are attached to beads
and further amplified. The concentration of each of the libraries was
determined with qPCR using the Ion Library Quantitation Kit (Life
Technologies, a part of Thermo Fisher Scientific Inc.), and the tem-
plate dilution factors were calculated. High-quality templated Ion
SphereTM particles, containing massively parallel clonally amplified
DNA, were prepared for the 200 base-read libraries using the Ion
PGMTM Template OT2 200 Kit and the Ion OneTouchTM 2 System
(Life Technologies, a part of Thermo Fisher Scientific Inc.). The
template-positive Ion SphereTM particles were enriched with the
Ion OneTouchTM Enrichment System (Life Technologies, a part of
Thermo Fisher Scientific Inc.) as per the manufacturer’s guidelines.
PGMTM Sequencing
Semiconductor sequencing on the Ion PGMTM detects the change
in pH when the proton (H+) is released during nucleotide incorpo-
ration. The sequencing was conducted on the Ion 318TM Chip v2
using the IonPGMTM Hi-QTM SequencingKit (six barcoded samples
per chip) coupled with the PGMTM sequencer (Life Technologies, a
part of Thermo Fisher Scientific Inc.). A chlorite cleaning, followed
by 18 MΩ water wash (Thermo Fisher Scientific, Millipore, MA)
was performed prior to the initialization of the Ion PGMTM System.
MPS Data Analysis
Commercially availableNextGENe R© software (v2.4.0.2) was used
to analyze all the sequences generated on the Ion PGMTM sequencer.
All the sequences were trimmed by 20 bases on both the 3′ and the
5′ ends and aligned to the mtDNA revised Cambridge Reference
Sequence (rCRS) [Andrews et al., 1999] (GenBank NC 012920.1).
The arbitrary threshold of 50 reads was considered as a minimum
required to address full sequencing coverage to reliably report vari-
ants/polymorphisms. This threshold is the coverageminimum to be
able to see heteroplasmies and to be able to clearly identify stochastic
sequencing errors. A BED file that contains the amplicon regions
was also uploaded for the analysis. The NextGENe R© software al-
lows visualization of sequence reads in addition to summarizing the
polymorphic sites in a tabular column.
The NextGENe R© software uses BLAST-like Alignment Tool to
align the sequence reads to the reference. Nonetheless, in some
cases, manual inspection was needed to confirm certain variants
and anomalies, especially regarding lengthheteroplasmy. It is known
that the corrected version of theCambridgeReference Sequence (the
rCRS) retained the same nucleotide numbering scheme as the orig-
inal reference sequence [the CRS; Anderson et al., 1981], and to
correct one of the erroneous positions, an “N” was recorded at po-
sition 3,107 to represent a deletion at that position [Andrews et al.,
1999]. The NextGENe R© software lists it as 3,107d in any tested
sample, but as this deletion does not represent a genuine sequence
variant, it shall be ignored. Additionally, this software does not ad-
here to the nomenclature recommendations detailed by the forensic
community [Carracedo et al., 2000; Bandelt and Parson 2008]. In
particular, rather than reporting the common dinucleotide deletion
in the dimeric repeat region between 514 and 524 as m.523A>del
and m.524C>del (placing the deletion at the most 3′ position pos-
sible), NextGENe R© employs a 5′ indel alignment and notes these
variants as m.513G>del and m.514G>del. Furthermore, we noticed
that the two sequential transitions that sometimes co-occur at po-
sitions 151 and 152 were instead reported as a deletion at np 151
and an insertion at 152, following the recommendations by Wilson
et al. (2000a, 2000b).
With the mtDNA sequence variants detected, the haplogroups
were inferred using the Web-based bioinformatics tool, MitoTool
[Fan andYao, 2011],whichuses themost recent versionof PhyloTree
(http://www.phylotree.org; Build 16) [van Oven and Kayser, 2009].
Results and Discussion
In recent years, DNA sequencing technology has evolved from
traditional Sanger sequencing of single reads to sequencing thou-
sands of reads with high coverage in a massively parallel fashion
with MPS technologies such as for analyzing human mtDNA [Sosa
et al., 2012, Parson et al. 2013, 2015; Davis et al, 2015]. Contrary
to the large-fragment sequencing strategy employed mostly so far
for MPS analysis of whole mt genomes [Sosa et al., 2012; Parson
et al., 2013], here we introduce an MPS approach for analyzing the
entire human mtDNA genome using 161 pairs of short amplicons
(144–230 bp, average 200 bp) in two different primer pools. We
demonstrate the whole mt genome coverage of our approach via
analyzing worldwide DNA samples belonging to different mtDNA
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Table 1. Performance Summary of the 20 Geographically Diverse DNA Samples for Whole mt Genome Sequencing with the MPS Tiling
Approach via 161 Short Overlapping Amplicons
Sample ID Total reads Aligned reads
Percent of
aligned reads
Maximum
coverage
Average
coverage
Percent of
coverage
1 641,486 535,003 83.40 67,847 5,593 100%
2 502,725 427,031 84.94 54,668 4,852 100%
3 268,055 224,250 83.66 68,677 4,494 100%
4 408,522 343,567 84.10 44,394 4,285 100%
5 355,691 305,619 85.92 50,539 3,804 100%
6 493,881 485,970 98 32,082 3,143 100%
7 289,696 258,720 89.31 43,687 2,607 100%
8 264,828 232,310 87.72 23,412 1,488 100%
9 264,231 204,023 77.21 47,124 3,777 100%
10 352,588 279,159 79.17 53,959 3,496 100%
11 476,939 426,050 89.33 66,262 5,637 100%
12 268,968 235,011 87.38 37,458 2,560 100%
13 249,338 198,790 79.73 46,631 1,840 100%
14 433,566 389,219 89.77 52,840 3,358 99.59%
15 541,295 532,291 98.34 44,460 3,488 100%
16 211,908 194,369 91.72 25,927 1,302 100%
17 307,441 278,527 90.60 30,230 1,865 100%a
18 324,954 299,098 92.04 48,897 2,006 100%
19 420,730 416,278 98.94 38,839 3,644 100%
20 249,701 241,699 96.80 37,051 2,628 99.62%
Average 366,327 325,349 88 45,749 3,293
aThe 9-bp deletion at np 8,281–8,289 in sample 17 is the defining mutation of haplogroup B. Hence, the coverage for sample 17 was considered to be 100% despite the 9-bp
deletion.
haplogroups, perform quality control via comparison with data ob-
tained with alternative methods in the same samples and provide
preliminary data on sensitivity testing, degraded DNA testing using
artificially and naturally degraded DNA, and multiple DNA sample
testing using barcoded adapters; the DNA variants were determined
using the NextGENe R© v2.4.0.2 software.
Method Application to Worldwide Samples and Quality
Comparison with Alternative Methods
To test the performance of the newly designed method for simul-
taneous whole mt genome sequencing using the Ion Torrent PGM,
we applied it to 20 carefully selectedDNA samples that belong to dif-
ferent global mtDNA haplogroups (Table 1). For these 20 samples,
the average sequencing coverage ranged from 1,302 to 5,637 reads
with an average of 3,293 reads across all samples. The total number
of reads per sample ranged from 211,908 to 641,486, with an average
across samples of 366,327, of which 88% were successfully aligned
to the rCRS (325,349 reads). Using a coverage threshold of 50 reads,
100% mt genome coverage was achieved in all the samples except
three (samples 14, 17, and 20), which each miss one small piece
of mtDNA sequence with our MPS approach (Table 1). In sam-
ple 17, the 9-bp deletion at np 8,281–8,289 (which is the defining
mutation of haplogroup B, among others) was not detected by the
NextGENe R© software in the final variant table, elucidating the cur-
rent limitation in the software package used. Further improvements
in the bioinformatics pipelines are needed to deal with such data.
A discreet manual inspection was done to confirm the deletion. In
samples 14 and 20, fragments of 66 bp (np 10,468–10,533) and 61
bp (np 10,269–10,329), respectively, were missed when using the
50-reads threshold applied. Figure 1 illustrates the average coverage
of each of the 161 amplicons across all the 20 samples. The mtDNA
variants detected for all the 20 samples analyzed are detailed in Supp.
Table S2.
Further, the whole mt genome data we generated via our MPS
approach from the samples belonging to the CEPH–HGDP panel
(samples 1–11) were compared with those previously reported by
Hartmann et al. (2009) based on whole mt genome sequencing us-
ing the Sanger approach. The remaining nine samples (12–20) we
analyzed via MPS were subjected to de novo Sanger sequencing of
the control region (unpublished study, data not shown). Some of
the positions in the coding region were further compared with the
results previously obtained from the five SNaPshot multiplex assays
established earlier (data not shown) [Chaitanya et al., 2014]. The
data obtained via our PGM method were then compared with the
data generated by alternative methods for quality control purposes.
The 9-bp deletion at np 8,281–8,289 in sample 17 was not tabu-
lated in the variant table generated by NextGENe R©. However, this
deletion was evident from results obtained with the SNaPshot mul-
tiplex assay and also apparent in the NextGENe R© viewer. Several
mis-calls by NextGENe R© were revised after a meticulous manual
inspection of the sequence in the NextGENe R© viewer. Disparities
observed between the Sanger sequencing/SNaPshot and MPS are
tabulated in Supp. Table S3. Some of the discrepancies were ob-
served in calling of the variants involving length heteroplasmy in
the polycytosine stretches of the HVS-I and HVS-II. In samples 1,
6, 11, and 17, due to an erroneous shift in the bases, the variant
was reported as m.16183A>M (an apparent heteroplasmy), instead
of m.16183A>C (a homoplasmic transversion) (Supp. Fig. S1A). In
the HVS-II region, for samples 8, 13, 16, 19, and 20, only one inser-
tion of the baseC in the np 303–309 regionwas reportedwith Sanger
sequencing. However, with MPS, two insertions of the base C were
noted (Supp. Fig. S1B). Such differences will in practice not have any
influence on haplogroup determination since the insertions at np
309, 315, 16,193, AC indels at 515–524, m.16182A>C,m.16183A>C,
andm.16519T>C are usually not considered for phylogenetic recon-
struction and are therefore not included in the PhyloTree [vanOven
and Kayser, 2009]. The variant reported as 357M in the samples
2, 7, 14, and 15 is specious and appears due to a shift in the base
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Figure 1. The average amplicon coverage, across all the 20 samples tested with the newly developedMPS tiling approach for whole mt genome
sequencing, are presented in three plots. A: Amplicons 1–53. B: Amplicons 54–106. C: Amplicons 107–161.
position, possibly because of the polyadenine stretches as shown
in Supp. Figure S2. Similarly, in samples 8, 12, and 17, the variant
m.13128C>M is spurious due to the shift in the base because of the
polycytosine stretches as shown in Supp. Figure S3.
Furthermore, spurious gapswereobserved in the samples 8 and12
at position 13,128 (Supp. Fig. S3 boxed region). Samples 9, 10, and
14 report an insertion 539.1C (Supp. Fig. S4), whichwas not evident
in the Sanger sequencing data. It has been described earlier that the
PGMproduces a high frequency of homopolymer sequencing errors
and indels [Loman et al., 2012; Seo et al., 2013]. In samples 2 and 4, a
spuriousdeletionwasnoticed at position5,824 thatwasnot reported
in the Sanger sequencing data of Hartmann et al. (2009) (Supp.
Fig. S5). Further, differences to the Sanger sequencingwere observed
in sample 9 at position 16,209 and in sample 10 at position 204
(Supp. Table S3; Supp. Fig. S6). Spurious single-bp deletions were
observed at some sequence positions in some reads in few of the
samples (Supp. Fig. S6 boxed region) but not reported in the variant
table. Such gaps did not influence the final consensus sequence and
therefore did not affect the final haplogroup determination.
One potential disadvantage of using a tiling approach based on
small amplicons over a large fragment amplification approach is the
potential detection of nuclear copies ofmt sequences (NUMTs)with
the tiling approach that likely are not detected with the long-range
approach simply becauseNUMTs typically aremuch smaller. To test
for this, we generated comparative whole mt genome sequencing
data using the previously described two overlapping 8.5-kb amplifi-
cation method [Fendt et al., 2009] in five of the samples (samples 1,
2, 3, 4, and 20) we used for PGM sequencing. It is noteworthy that
the variants detected were in concordance with those detected when
sequenced with the short overlapping fragments, except in sam-
ple 2. In sample 2, the polymorphisms m.10664C>Y, m.8251G>R,
and m.8252C>M (Supp. Fig. S7; Table 2) were discordant with the
tiling approach (m.10664C>T, m.8251G>A, and no variant at po-
sition 8,252, respectively). The erroneous calling at positions 8,251
and 8,252 could be due to the base position shifts as seen in Supp.
Figure S7. The disparities observed in the HVS-I and HVS-II due to
the length heteroplasmy were also noticed with the long-range am-
plification. Hence, from the samples analyzed, we have no evidence
that our tiling MPS approach picks up NUMTs.
It has been described earlier [Parson et al., 2013; Seo et al., 2015]
that false deletions were observed in the mtDNA sequencing data
generatedusing thePGM.However, no suchdeletionswereobserved
when the variants reported with our tool and the long-range PCR
approach was compared. Except for the discordant calls in sample 2,
no other differences in variant calling were observed. Nonetheless,
this may change when more samples are tested, as in this study only
a few samples have been tested.
Point heteroplasmies at 22 positions in 14 samples were re-
ported in the NextGENe R© variant table: sample 1: m.8155G>R;
sample 2: m.1048C>Y, m.357A>M; sample 3: m.14423G>S; sample
4: m.4788G>R, m.14921G>R; sample 5: m.1171A>R, m.13020T>Y,
m.15326A>R, m.16189T>Y; sample 6: m.7759T>Y; sample 7:
m.771A>R, m.4248T>Y, m.357A>M; sample 8: m.3296T>Y,
m.13128C>M; sample 9: m.10185C>Y, m.15326A>R, m.16209T>Y;
sample 10: m.204T>Y, m.13928G>S, m.15326A>R, m.14831G>R;
sample 12: m.13128C>M; sample 14: m.357A>M; sample 15:
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Table 2. Differences Between the Previously Developed Long-Range Amplification MPS Approach and the Newly Introduced MPS
Tiling Approach for Whole mt Genome Analysis Both Obtained via the PGM in Sample 2
NGS data from NextGENe R© software
%A %C %G %T %Insertions %Deletions
Long range m.10664C>Y 0 17.46 0 78.31 0 4.23
Tiling m.10664C>T 0 0.34 0 99.35 0 0.3
Long range m.8251G>R 71.43 0 28.57 0 0 0
m.8252C>M 29.37 70.63 0 0 2.1 0
Tiling m.8251G>A 97.27 0 2.1 0 0 0.63
Human mitochondrial genome, rCRS (GenBank NC_012920.1).
m.357A>M; and sample 17: m.13128C>M. Heteroplasmy threshold
was set at 20% (of total coverage) [Parson et al., 2013]. Out of the
22, only seven of the point heteroplasmies (sample 1: m.8155G>R;
sample 3: m.14423G>S; sample 4: m.4788G>R, m.14921G>R; sam-
ple 5: m.1171A>R, m.16189T>Y; sample 6: m.7759T>Y) were also
observed in the Sanger sequencing data ofHartmann et al. (2009). A
heteroplasmy at position 3,296 was not reported by Hartmann et al.
(2009), contrary to the m.3296T>Y from this study. However, in a
recent publication, wherein some samples from the CEPH-HGDP
panel were resequenced on the Illumina platform, a variant at 3,296
was recorded for the sample 8 as m.3296T>N [Lippold et al., 2014],
suggesting that this heteroplasmy could be genuine.
In general, the availability of a viewer in the NextGENe R© soft-
ware proved advantageous in manually evaluating the discrepan-
cies and solving them accordingly, especially in assessing the true
heteroplasmy.
mtDNA Haplogroup Assignment and Maternal Ancestry
Inference
The haplogroups for the 20 samples were inferred from the ob-
tained whole mtDNA genome data using MitoTool [Fan and Yao,
2011] and are presented in Table 3 together with the geographic
sampling origin and the previously reported geographic region of
haplogroup origin indicative of maternal biogeographic ancestry.
All the haplogroups determined for the 20 samples were in agree-
ment with their biogeographic origin. It is important to assert that
mtDNA construes only the matrilineal ancestry information of an
individual. To achieve comprehensive biogeographic ancestry in-
ference from DNA, in addition to the global matrilineal biogeo-
graphic ancestry assignment, information about paternal ancestry
using male-specific Y-chromosomal DNA (in the case of males)
and from biparental ancestry using ancestry-informative autosomal
DNA markers have to be considered [Kayser and de Knijff, 2011].
Preliminary Sensitivity Testing
In order to determine the limit of detection provided the 50 reads
coverage threshold used and given the sensitivity of the developed
PGM assay, preliminary sensitivity tests were performed with dif-
fering starting amounts of DNA at 100, 250, and 500pg, and 1
and 10 ng (measured as genomic DNA). For this, we used three of
the 20 DNA samples originating from different populations with
different haplogroups—South Africa with haplogroup L3d3a1a
(sample 1); Italy with T2b (sample 15); and The Netherlands with
V3c (sample 19). The results of the sensitivity study on the sam-
ples are summarized in Supp. Table S4. For all the sample dilutions,
it was possible to detect the correct haplogroup down to merely
100 pg input genomic DNA, even though the input manufacturer’s
recommendation for library construction is 10 ng. Regarding whole
mt genome coverage, we achieved 100% for all sample dilutions,
except for sample 19 at 250 pg (99.89% at 576 reads on average),
and for all three samples at 100 pg (99.93% at 2,591 average reads,
99.91% at 1,175 average reads, and 99.74% at 462 average reads for
samples 1, 15, and 19, respectively). Notably, samples were further
diluted to 50 pg input, but could not proceed to sequencing as the
template dilution factors calculated were below one, whereas one is
recommended by the manufacturer, thus implying that the amount
of DNA library generated from such low quantity DNA samples
was not sufficient to perform optimal emulsion PCR [Ralf et al.,
2015]. Previous studies have shown that it is possible to achieve
successful sequencing results with the Sanger protocol using 50 pg
of input DNA, and sometimes even at 10 pg of input DNA with
minimal failures [Lyons et al., 2013; Just et al., 2014]. However, to
achieve full mtDNA coverage at a high resolution with the Sanger
approach, several individual sequences are required, as opposed to
the parallel nature of the MPS where a high volume of data is gen-
erated in relatively short time. Though it was possible to achieve
correct haplogroup information at 100 pg, increasing the number
of PCR cycles could result in good coverage with input below 100
pg of DNA. Hence, further testing needs to be done to show the
full-sensitivity limits of this system.
Preliminary Analysis of Experimentally and Naturally
Degraded DNA Samples
The robustness of our MPS assay regarding DNA degradation
was tested by sequencing experimentally and naturally degraded
DNA samples. Aliquots of a sample (1 ng genomic DNA), belong-
ing to haplogroup M35a1, was subjected to DNase treatment at
different time intervals: 5, 10, 15, 20, 30, and 45 min. The effect
of DNA degradation in these samples was first monitored by an-
alyzing them with the AmpFlSTR R© Identifiler R© PCR Amplifica-
tion Kit (Applied Biosystems) targeting 15 autosomal STRs plus
the amelogenin sex typing system, which is routinely used for hu-
man identification purposes (Fig. 2). From Figure 2, it is evident
that the DNA degradation-induced STR locus dropouts are clearly
correlated with PCR fragment size, as expected. Particularly, at 5
min of DNase treatment, there were complete locus dropouts at
three STRs CSF1PO (allelic fragment length 330 bp), FGA (280 bp),
and D2S1338 (310 bp); at 10 min, additional dropout at D7S820
(271 bp), D16S539 (280 bp), and D18S51 (270 bp); at 15 min,
additional dropouts at TPOX (238 bp) and D13S317 (222 bp); at
20min, additional dropout at D21S11 (206 bp), TH01 (172 bp), and
vWA (178 bp); at 30 min, additional dropout at D5S818 (154 bp),
D8S1179 (146 bp), and D19S433 (128 bp). After 45 min of DNase
treatment, all of the 16 loci covering allelic fragment sizes of about
128–330 bp dropped out, except the two loci with shortest alleles,
HUMANMUTATION, Vol. 36, No. 12, 1236–1247, 2015 1241
Table 3. Haplogroups of the 20 DNA Samples Whole mt Genome Sequenced with the MPS Tiling Tool and Interpreted Using MitoTool
Sample ID Haplogroup Broad haplogroup Known sampling region
Main geographic region of the
(broad) haplogroup origin References
1 L3d3a1a L3∗(xM,N) South Africa Africa, West Asia Behar et al. (2008)
2 L0d1a1a (199 missing) L0 South Africa Southern Africa Behar et al. (2008); Barbieri
et al. (2013)
3 H1c H Russia (Caucasus) West Eurasia, Northern Africa Loogva¨li et al. (2004); Achilli
et al. (2004); Roostalu et al.
(2007)
4 U7a2 U7 Israel West Eurasia, Central Asia,
Southern Asia
Palanichamy et al. (2004);
Brisighelli et al. (2009)
5 P1d1 P New Guinea Oceania (Papuan, Melanesian,
and Australian Aborigines)
Friedlaender et al. (2007);
Hudjashov et al. (2007)
6 V HV∗(xH) Algeria West Eurasia, Northern Africa Achilli et al. (2005);
A´lvarez-Iglesias et al. (2009)
7 A1a1 (missing 235) A∗(xA2) China East Asia Kong et al. (2006); Derenko
et al. (2007)
8 J2b1a J Italy West Eurasia Pala et al. (2012)
9 M7c1a2a M∗(xM1,C,D) China South Asia, East Asia, Southeast
Asia
Kong et al., 2006; Derenko et al.
(2007)
10 F4a1a R9 China East Asia, Southeast Asia Kong et al. (2006)
11 X2b5 X Orkney Islands West Eurasia, Northern Africa,
Americas
Reidla et al. (2003); Achilli et al.
(2008)
12 J2b1(J2b1a1: missing16278) J Italy West Eurasia Pala et al. (2012)
13 P P Australia (Aborigine) Oceania (Papuan, Melanesian,
and Australian Aborigines)
Friedlaender et al. (2007);
Hudjashov et al. (2007)
14 M72a M∗(xM1,C,D) Thailand South Asia, East Asia, Southeast
Asia
Tabbada et al. (2010); Peng et al.
(2010)
15 T2b T Italy West Eurasia Pala et al. (2012)
16 K1a12 U The Netherlands West Eurasia Achilli et al. (2005); Behar et al.
(2006)
17 B5a1a B5 The Netherlands East Asia Kong et al. (2006)
18 W5a1a W The Netherlands West Eurasia Finnila¨ et al. (2001);
Palanichamy et al. (2004)
19 V3c HV∗(xH) The Netherlands West Eurasia, Northern Africa Achilli et al. (2005);
A´lvarez-Iglesias et al. (2009)
20 H23 H The Netherlands West Eurasia, Northern Africa Loogva¨li et al. (2004); Achilli
et al. (2004); Roostalu et al.
(2007)
amelogenin (108 bp) and D3S1358 (116 bp). This analysis pro-
vides a rough idea on DNA fragmentation in these experimentally
degraded samples as relevant for the subsequent mtDNA genome
sequencing using our MPS tiling approach.
Table 4 enlists theperformance summaryof ourwholemt genome
tiling MPS approach in the DNase-treated samples at different time
intervals. Most notable, for the samples degraded for 5, 10, and 15
min, we obtained 100% mt genome coverage using a 50x thresh-
old, at 6,810, 3,886, and 3,007 average reads, respectively. Prior STR
analysis showed that eight loci with allelic fragment length from
222 to 330 bp already dropped out in these three degraded samples.
For samples degraded for 20, 30, and 45 min, the coverage dropped
down to 94.4%, 82.6%, and 19.25%, respectively, at 2,073, 1,183,
and 487 average reads, respectively. Regarding the total number of
mtDNA variants detected in these samples, after 5 min of DNase
treatment, it was 37 as well as after 10 and 15 min where we ob-
tained 100% mt genome coverage, whereas it dropped down to 30,
24, and 13 in the samples that received DNase treatment for 20, 30,
and 45 min, respectively. However, despite the loss of reads, frag-
ments, and thus DNA variants, it was still possible to determine the
correct mtDNA haplogroup (M35a1) in all degraded DNA sam-
ples from 5 to 45 min of DNase treatment. Figure 3 elucidates the
average amplicon coverage across all amplicons for the different
time intervals of enzymatic degradation clearly showing the loss
of sequence reads with increased degradation time, as expected.
Figure 4 illustrates the amplicon coverage according to amplicon
length for the different time intervals of enzymatic degradation,
clearly demonstrating the effect of DNA degradation on amplicon
length andnumber of reads. It is to be noted that successful sequenc-
ing achieving 100% mt genome coverage was obtained from de-
graded DNA samples with a maximal fragment size of about 220 bp
(Fig. 2).
To test two additional experimental degradation methods,
aliquots of 1 ng genomic DNA of sample 15, belonging to hap-
logroup T2b, were exposed to UV radiation for 30 min using a
Bio-Link (Vilber Lourmat) at a strength of 50 J/cm2 and enzymatic
shearing using the Ion ShearTM Plus Reagents Kit (Life Technologies,
a part of Thermo Fisher Scientific Inc.). The performance summary
of the samples is depicted in Table 4. At 1 ng unexposed DNA,
the total number of mtDNA variants detected was 41 at 100% mt
genome coverage (1,865 reads on average); when the sample was
exposed to UV for 30 min, only 38 of the 41 variants were detected
(missed variants were m.7310T>C, m.8697G>A, and m.10463T>C)
with a mt genome coverage of 88.65% at 1,362 reads on average. At
position 13,368, the variant was reported as m.13368G>R (49.36%
A and 50.61% G), whereas the true variant was m.13368G>A. In
contrast, all the 41 variants were correctly detected when the sample
was subjected to enzymatic shearing, even though only 89.9% mt
genome coverage was obtained at 975 reads on average. The vari-
ant m.357A>M, which was explained earlier as a sequencing error
probably because of a base shift position due to the poly-A stretch,
was detected in both degradation approaches. However, both
degradation methods allowed our MPS approach to determine the
correct haplogroup of sample 15 (i.e., T2b).
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Figure 2. STRprofiles from theAmpFlSTR R© Identifiler R© PCRAmplification Kit (AppliedBiosystems) targeting 15 autosomal STRs plus amelogenin
to illustrate the degree of DNA fragmentation for the sample treated with DNase at different time intervals: 5, 10, 15, 20, 30, and 45 min.
Additionally, DNA extracts from six human remains (i.e., teeth
and bones) were sequenced with our MPS tiling approach to inves-
tigate naturally degraded DNA (Table 4). Notably, samples 1, 3, 4,
and 5 delivered a complete 16 loci (15 STRs plus amelogenin) DNA
profile with the AmpFSTR R© NGMTM Kit (Thermo Fisher Scien-
tific) regularly used for human identification, whereas samples 2
and 6 delivered only a partial NGM profile with 12 and 10 of the 16
loci missing, respectively. With our MPS approach, we obtained mt
genome coverage of close to 90% for samples 1, 3, and 4, whereas
for samples 6, 5, and 2, our method delivered 75%, 60%, and 50%
of mt genome coverage (Table 4). Notably, sample 2 with the low-
est observed mt genome coverage of 50% (225 reads on average)
likely originates from the XV–XVI century. For samples 4, 5, and 6,
mtDNA control region HVI and HVII data were obtained success-
fully via Sanger sequencing and compared with those of the tiling
MPS approach. Sanger sequencing of these samples was performed
as part of another unpublished study and hence the protocol was
not described here. These data were comparable, except that the
variant m.16519T>C, which was clearly evident in the tiling MPS
approach, but was not reported in the Sanger sequencing data for
all the three samples. However, Sanger sequencing mtDNA control
region data were not available for samples 1, 2, and 3.
Although mt genome coverage was only obtained to the degree
of 50%–90% from these six naturally degraded DNA samples, our
MPS tiling approach allowedhaplogroup assignment for all of them:
U5b2b, H4a1, H, T2b, U4a2, and T1a for samples 1–6, respectively.
The AmpliSeq-based MPS approach we developed here for com-
plete human mt genome analysis is designed for and suited to
nondegraded and mildly to considerably degraded DNA leading
to DNA fragmentation down to a size range of around 200 bp and
larger, as often confronted with in forensic, medical, and anthro-
pological studies. Our approach is not suitable for more severely
degraded DNA as often confronted with in ancient DNA studies.
For such strongly fragmented DNA, hybridization capture meth-
ods are more suitable than AmpliSeq-based approaches and have
been developed in the field of ancient DNA research [Noonan et al.,
2005; Anderung et al., 2008; Briggs et al., 2009; Templeton et al.,
2013]. The AmpliSeq system we used in our approach is optimized
for this kind ofmultiplexed amplification and theworkflow requires
fewer steps, which reduces the chance of contamination andmix-up.
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Table 4. Performance Summary of PGM-Based Whole mt Genome Sequencing of DNase-Treated Sample at Different Time Intervals
Total reads Aligned reads
Percent of
aligned reads
Maximum
coverage
Average
coverage
Percent of
coverage Haplogroup
DNase-treated sample at
different time
intervals
5 min 463,854 452,505 97.55% 51,989 6,810 100% M35a1
10 min 242,109 234,156 96.72% 45,167 3,886 100%
15 min 163,854 152,505 93.07% 38,249 3,007 100%
20 min 60,988 59,085 96.88% 31,262 2,073 94.40%
30 min 83,565 80,367 96.17% 10,731 1,183 82.60%
45 min 15,642 13,606 86.98% 9,625 487 19.25%
Sample 15 UV for 30 min 258,179 255,277 98.88% 21,901 1,362 88.65% T2b
Enzymatic shearing 315,030 278,648 88.45% 5,827 975 89.90%
Ancient and degraded
bone and teeth
samples
Sample 1 542,889 525,140 96.73% 9,572 4,042.52 87.87% U5b2b
Sample 2 95,396 58,311 61.13% 2,379 225.57 50.36% H4a1
Sample 3 538,548 512,826 95.22% 7,273 3,321.23 90.12% H
Sample 4 529,929 480,856 90.74% 6,048 3,141.47 88.32% T2b
Sample 5 477,578 450,506 94.33% 8,218 2,924.11 59.59% U4a2
Sample 6 175,642 140,021 79.72% 3,535 612.48 75.25% T1a
Sample 15 subjected to three different degradation methods and six different highly degraded bone and teeth samples.
Figure 3. The average mt DNA amplicon coverage across all amplicons for the DNase-treated sample at the different time intervals as obtained
with the MPS tiling approach.
Additionally,more targets are generatedwith theAmpliseq PCR sys-
tem than with a hybridization capture-based system, allowing for
deeper coverage, mitigating sequencing errors.
Preliminary Testing of Sample Multiplexing via DNA
Barcoding
In order to test the feasibility of sequencing multiple samples si-
multaneously in one sequencing run, barcode adapters were used.
Six DNA samples were pooled (12 libraries, as two primer pools
were needed) per each sequencing run and barcoded, using the Ion
XpressTM Barcode Adapters (Life Technologies, a part of Thermo
Fisher Scientific Inc.). The ability to multiplex six samples via bar-
coding is a valuable asset with regard to the increase in throughput
and cost-effectiveness. Further research should involve sequencing
more than six samples in a single run on one chip.
Conclusion
Our study shows that analyzing the complete human mt genome
in a simultaneous way via a tiling approach targeting short ampli-
cons is feasible. With the short overlapping fragments we employed
in covering the entire mt genome, and supported by our prelimi-
nary data on experimentally and naturally degraded DNA samples,
we expect our approach to be particularly useful for analyzing de-
graded materials. As this was a preliminary study introducing the
newmethod, future studies with a larger sample set including more
degraded samples need to be conducted to explore the complete
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Figure 4. A: The amplicon coverage (number of times ampliconswere observed in theMPS data) of all the 161 amplicons used to obtain complete
mt genome coverage with our MPS approach, arranged according to amplicon length from the shortest amplicon used (144 bp) on the left-hand
side to the largest amplicon used (230 bp) on the right-hand side, for the different time intervals of enzymatic DNA degradation: 5, 10, 15, 20, 30, and
45 min. All the amplicons below X represents the coverage below the 50 reads threshold. B: Additional zoomed-in image of the longer amplicons
from amplicon lengths of 206 bp (left-hand side) to 230 bp (right-hand side).
value of this tool. However, based on the preliminary data presented
here, we already expect our method to be highly useful in many
mtDNA applications using degraded and nondegraded DNA where
maternal lineage identification and maternal ancestry inference on
the maximum possible resolution level is appreciated such as in
forensic, anthropological, and medical genetics.
In the longer run, we envision this MPS tool for complete mt
genome analysis allowing maximal maternal lineage determination
andmaternal ancestry inference being combinedwithMPS tools for
ultra-high-resolution paternal lineage and paternal ancestry iden-
tification, such as the PGM tool we recently introduced for simul-
taneous analysis of >530 Y-chromosomal SNPs allowing to detect
>430 worldwide Y haplogroups [Ralf et al., 2015]. Since with the
current whole mt genome tool using 161 short overlapping ampli-
cons (144–230 bp, average 200 bp), the sequence capacity limits of
the PGM (or alternative devices such asMiSeq) are not reached, fur-
ther enlargements of combined targetedMPS tools may be expected
from future work. For instance, we envision the additional addi-
tion of autosomal ancestry-informative SNPs into combined tools
together with Y and mtDNA allowing to not only detect lineages
(as possible with mtDNA and Y analysis) but moreover to resolve
individual genetic admixture, and to obtain an overall andmore ex-
tensive estimate of an individual’s biogeographic ancestry from all
three ancestry components: maternal, paternal, and biparental. For
some applications, such as to answer forensic and anthropological
questions, the additional incorporation of phenotypic markers into
comprehensive ancestry tool(s) such as SNPs predictive for human
pigmentation traits or for other externally visible characteristics if
available [Kayser, 2015] would further add to the investigative value
available with such comprehensive targeted MPS tools.
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